Post hoc multiple comparisons showed a significantly higher intensity of GFAP-IR in HCC mice than in PB controls in the late dark/active phase (ZT20, p = 0.003) (Figure 6D,H,I). This evidence concerns the gene GFAP and hepatocellular carcinoma.